Sector Alpha Week of 2026-09-17
Not SEBI Registered !! Not Investment advice !!
Sector Alpha — machine-written from the numbers · Data as of 2026-09-17

BWX Technologies, Inc.

BWXT
Industrials · Aerospace & Defense

BWX Technologies, Inc.'s earnings have outrun its stock. EPS grew +16.6% in a year against a −16.5% price move.

The sharpest disagreement: annual EPS moved +16.6% against a −16.5% price move — the market has not yet caught up with the delivery.

The price is building a base (12 weeks in) while the P/E sits at the 63rd percentile of its own 5-year range. Underneath, the last four quarters read improving — profit +12.5% year on year, and 145% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Mixed
fundamental trajectory, 12 quarters
Price
$146
−16.5% 1Y
P/E
37.7×
63rd pctile
of its own 5-year range
Revenue (Mar 26)
$0.9 B
+26.5% YoY
Profit (Mar 26)
$0.1 B
+12.5% YoY
Operating margin
10.5%
−1.3 pp YoY
ROE
28%
FY25
ROIC
10.8%
vs WACC 7.4% → +3.4 pp
Cash conversion
145%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

BWX Technologies, Inc. trades at $146, building a base and 12 weeks into that stage. That is −24.1% against its own 200-day average. It sits at 0% of a 52-week range of $146 to $236. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (20 weeks and counting).

Today the stock is building a base — week 12 of stage 1. At $146 it trades −24.1% versus its 200-day average and sits at 0% of its 52-week range ($146–$236).

Sep 26: $146 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
−24.1% versus the 200-day line, week 12 of stage 1
Price50-day avg200-day avg
S2S1S2S1$249$200$150$101$51.1$$146$192Sep 23Jun 24Mar 25Dec 25Sep 26
S2S1S2S1$249$200$150$101$51.1$$146$192Sep 23Mar 25Sep 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (533 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 16Sep 26

Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved +308% while the S&P 500 moved +255% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (20 weeks and counting; last ahead the week of 2026-05-01) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

BWX Technologies, Inc. trades at 37.7× P/E, mid-range by its own standards (63rd percentile). Its long-run median P/E is 33.3×, measured across 4.5 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 37.7× is mid-range by its own standards (63rd percentile), against a long-run median of 33.3× measured over 4.5 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 37.7× vs a 33.3× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 4.5-year window; loss-period spikes above 61× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
mid-range by its own standards (63rd percentile)
P/EMedianEPS (TTM) (quarterly)
64.7×$4.051.3×$3.037.9×$2.024.5×$1.011.2×$0.0×$38.95×$4Apr 22May 23Jun 24Aug 25Sep 26
64.7×$4.051.3×$3.037.9×$2.024.5×$1.011.2×$0.0×$38.95×$4Apr 22Jun 24Sep 26
PEG 3.53 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 19 quarters.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
4.4×3.5×2.6×1.7×0.7××3.53×Sep 21Sep 22Dec 23Dec 24Mar 26
4.4×3.5×2.6×1.7×0.7××3.53×Sep 21Dec 23Mar 26
P/E
37.7×
63rd percentile of 5y
PEG
2.32
as reported

Why the multiple sits where it does: over the past year annual EPS moved +16.6% against a −16.5% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 3y, of the +24.9%/yr price move, ~+15.1%/yr came from earnings growth and ~+9.8 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

BWX Technologies, Inc. reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 10.6% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 4 curves, on full evidence.

Growth, year by year: revenue +18.5% in FY25, profit +17.9% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
20%21%16%9.4%12%−2.4%8.0%−14%4.1%−26%%%18.5%17.9%FY21FY23FY25
20%21%16%9.4%12%−2.4%8.0%−14%4.1%−26%%%18.5%17.9%FY21FY23FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue accelerating, profit stabilising
RevenueProfitEPS
23%32%19%15%14%−0.8%10.0%−17%5.7%−34%%%21.6%17.2%19.1%Jun 23Sep 24Mar 26
23%32%19%15%14%−0.8%10.0%−17%5.7%−34%%%21.6%17.2%19.1%Jun 23Sep 24Mar 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
15%14%13%11%10%%10.6%Jun 23Dec 23Sep 24Jun 25Mar 26
15%14%13%11%10%%10.6%Jun 23Sep 24Mar 26
Revenue growth
Rising
latest +21.6% · span +6.9% to +21.6%
Profit growth
Steady high
latest +17.2% · span −29.0% to +27.3%
EPS growth
Rising
latest +19.1% · span −28.0% to +23.8%
ROCE
Stuck low
latest 10.6% · span 10.6%–14.6%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+18.5%+12.8%
Profit+17.9%+11.2%
EPS+16.6%+11.3%
Stock price−16.5%+24.9%+21.4%+14.3%
Revenue YoY (Mar 26)
+26.5%
latest quarter vs a year ago
Profit YoY (Mar 26)
+12.5%
latest quarter vs a year ago
Revenue 10y
10.8%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

34.2/100 — rank 27 of 30 in Aerospace & Defense · 66% evidence confidence

BWX Technologies, Inc. scores 34.2 out of 100 against the 30 companies it is compared with in Aerospace & Defense, ranking 27. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 16.4 + 11.2 + 5.3 + 1.3 = 34.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

BWX Technologies, Inc. reported $0.9 B of revenue in the Mar 26 quarter, +26.5% year on year. That is the 12th straight quarter of year-on-year growth. Over 4 years it has compounded at 10.8% a year. The last full year, FY25, came in at $3.2 B. The last four reported quarters add to $3.4 B.

FY25 revenue came in at $3.2 B (+18.5% on the year), capping 4 years at 10.8% compound. The latest quarter (Mar 26) printed $0.9 B, +26.5% year on year — the 12th consecutive quarter of year-over-year growth.

FY25 revenue $3.2 B (+18.5% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
10.8% a year over 4 years
RevenueYoY growth
3.520%2.616%1.712%0.98.0%0.04.1%$ B%$3B18.5%FY21FY23FY25
3.520%2.616%1.712%0.98.0%0.04.1%$ B%$3B18.5%FY21FY23FY25
Mar 26: $0.9 B (+26.5% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
12th straight quarter of growth
Revenue (quarterly)YoY growth
1.032%0.724%0.516%0.28.4%0.00.5%$ B%$1B26.5%Jun 23Sep 24Mar 26
1.032%0.724%0.516%0.28.4%0.00.5%$ B%$1B26.5%Jun 23Sep 24Mar 26

Pace check: the last four quarters averaged +21.7% growth against the decade's 10.8% — the current year is running faster than its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +21.6% over the last 4 quarters against +15.6%/yr over the last 8 — accelerating; TTM profit +17.2% vs +14.4%/yr — stabilising.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

BWX Technologies, Inc.'s operating margin is 10.5% in the Mar 26 quarter, −1.3 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 10.3% to 14.6%. The current quarter sits inside that band.

The latest quarter's operating margin is 10.5%, −1.3 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 10.3%–14.6%.

🚨 Why the margin moved: operating margin went −1.3 pp year on year while gross margin went −1.7 pp — the loss came mostly from the gross line: input costs and pricing.

FY25: 10.3% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
within a 10.3–14.6% band over 5 years
operating marginYoY change (pp)
15%−0.2%14%−0.6%12%−1.0%11%−1.3%10.0%−1.7%%%10.3%−1.6%FY21FY23FY25
15%−0.2%14%−0.6%12%−1.0%11%−1.3%10.0%−1.7%%%10.3%−1.6%FY21FY23FY25
Mar 26: 10.5% operating margin (−1.3 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
16%2.2%14%0.4%12%−1.4%9.4%−3.1%7.3%−4.9%%%10.5%−1.3%Jun 23Sep 24Mar 26
16%2.2%14%0.4%12%−1.4%9.4%−3.1%7.3%−4.9%%%10.5%−1.3%Jun 23Sep 24Mar 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

BWX Technologies, Inc. earned $0.1 B of net profit in the Mar 26 quarter, +12.5% year on year. It is the 5th consecutive quarter of growth. Full-year FY25 profit was $0.3 B. The 4-year compound rate is 1.6%. That is 10.5% of the quarter's revenue. The same quarter a year earlier earned $0.1 B.

Mar 26 profit was $0.1 B, +12.5% year on year — the 5th consecutive quarter of growth. On the full year, FY25 printed $0.3 B (+17.9%), and the 4-year compound rate is 1.6%.

FY25 profit $0.3 B (+17.9% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
1.6% a year over 4 years
Net profitYoY growth
0.421%0.39.4%0.2−2.4%0.1−14%0.0−26%$ B%$0B17.9%FY21FY23FY25
0.421%0.39.4%0.2−2.4%0.1−14%0.0−26%$ B%$0B17.9%FY21FY23FY25
Mar 26: $0.1 B (+12.5% YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
5th straight quarter of growth
Net profit (quarterly)YoY growth
0.1082%0.0756%0.0530%0.024.5%0.00−21%$ B%$0B12.5%Jun 23Sep 24Mar 26
0.1082%0.0756%0.0530%0.024.5%0.00−21%$ B%$0B12.5%Jun 23Sep 24Mar 26

Why profit moved: revenue contributed +26.5% and the margin −1.3 pp — the quarter was revenue-led, with the margin roughly flat.

Pace comparison, last four quarters: profit +17.4% vs revenue +21.7%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.

08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 145% of BWX Technologies, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.5 B of operating cash against $0.3 B of profit. After $0.2 B of capital spending, $0.3 B was left as free cash.

FY25: operating cash of $0.5 B against reported profit of $0.3 B, leaving free cash of $0.3 B after $0.2 B of capital spending. Across the last 3 fiscal years the conversion rate is 145% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO $0.5 B vs profit $0.3 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
145% of 3-year profit arrived as cash
Operating cashNet profitFree cash
0.50.40.30.10.0$ B$1B$0B$0BFY21FY23FY25
0.50.40.30.10.0$ B$1B$0B$0BFY21FY23FY25
Mar 26: operating cash $0.1 B = 100% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.30429%0.23325%0.15222%0.08118%0.0014%$ B%$0B100%Jun 23Sep 24Mar 26
0.30429%0.23325%0.15222%0.08118%0.0014%$ B%$0B100%Jun 23Sep 24Mar 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

BWX Technologies, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY25: capex $0.2 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.330.250.170.080.00$ B$0BFY21FY23FY25
0.330.250.170.080.00$ B$0BFY21FY23FY25
Mar 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
0.080.240.060.170.040.110.020.040.00−0.03$ B$ B$0B$0BJun 23Sep 24Mar 26
0.080.240.060.170.040.110.020.040.00−0.03$ B$ B$0B$0BJun 23Sep 24Mar 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

BWX Technologies, Inc. earns a ROE of 27% in FY25. Return on invested capital clears the cost of that capital by +3.4 percentage points, so growth here adds value rather than only size. The wiring behind it is 10.3% net margin on 0.75× asset turns.

FY25 ROE is 27%.

Why the return is what it is — the wiring (FY25): 10.3% net margin × 0.75× asset turns × 3.47× balance-sheet leverage ≈ 26.8% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 10.8% − 7.4% = a +3.4 pp spread. The 7.4% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

FY25: ROE 27% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 7.4% cost of capital used on this page.
the full ladder
ROEROIC (annual)WACC
52%40%28%16%4.1%%26.8%11.4%FY21FY23FY25
52%40%28%16%4.1%%26.8%11.4%FY21FY23FY25
Mar 26: ROIC 10.4% (TTM) vs WACC 7.4% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
34%27%20%13%5.4%%10.4%30.1%Jun 23Sep 24Mar 26
34%27%20%13%5.4%%10.4%30.1%Jun 23Sep 24Mar 26
11 · Dividend

Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.

BWX Technologies, Inc. paid $1.02 per share over the last four reported quarters, up 8.0% on a year ago. The most recent declaration was $0.27 for Mar 26. Against the current price of $146 that is a trailing yield of 0.70%, measured on dividends already paid rather than on a forecast.

BWX Technologies, Inc. paid $1.02 per share across the last four reported quarters, most recently $0.27 for Mar 26. That is up 8.0% against the same quarter a year earlier. Against the current price of $146 the trailing twelve months work out to 0.70% — trailing dividends measured against today's price, not a forward estimate.

Dividend per share by quarter Declared dividend per share, $ B, per reported quarter. 12 quarters on file.
latest $0.27 (Mar 26)
Dividend per share
0.290.220.150.070.00$ B$0BJun 23Dec 23Sep 24Jun 25Mar 26
0.290.220.150.070.00$ B$0BJun 23Sep 24Mar 26
12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

BWX Technologies, Inc. carries total debt of $2.0 B against shareholder equity of $1.3 B as of Mar 26, a debt-to-equity of 1.58. On the annual view that ratio went from 1.86 in FY21 to 1.64 in FY25. Read the returns elsewhere on this page with that leverage in mind.

Mar 26: total debt of $2.0 B against shareholder equity of $1.3 B — a debt-to-equity of 1.58. On the annual view, debt-to-equity went from 1.86 (FY21) to 1.64 (FY25). Read the returns on this page with that leverage in mind.

FY25: debt $2.0 B at 1.64× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
2.21.9×1.61.7×1.11.4×0.51.2×0.00.9×$ B×$2B1.64×FY21FY23FY25
2.21.9×1.61.7×1.11.4×0.51.2×0.00.9×$ B×$2B1.64×FY21FY23FY25
Mar 26: debt $2.0 B, debt-to-equity 1.58 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
2.21.7×1.61.5×1.11.3×0.51.1×0.00.9×$ B×$2B1.58×Jun 23Sep 24Mar 26
2.21.7×1.61.5×1.11.3×0.51.1×0.00.9×$ B×$2B1.58×Jun 23Sep 24Mar 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

3.3% of BWX Technologies, Inc.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 2.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 3.3% of the float is sold short, and at typical trading volumes it would take about 2.9 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
3.3%
of the tradable float
Days to cover
2.9
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

BWX Technologies, Inc.: the Z-score reads 5.54. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 5.54 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 5.54.

15 · Related companies · Aerospace & Defense
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Lockheed Martin CorporationLMT 72.1/100Favorable setup81% evidence TURNING 25.6/35 Revenue 7.2% · PAT 49.5% · OPM change 8.3 pp 83% evidence 14.5/25 ROCE 6.8% · OPM 12.4% 76% evidence 16.1/20 P/E 18.7× · PEG 0.35 65% evidence 15.9/20 RS sector 5.2% · RS bench -8% · 1Y 13.6%4 of 12 weeks ahead 100% evidence
Exact sum: 25.6 + 14.5 + 16.1 + 15.9 = 72.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2RTX CorporationRTX 65.8/100Favorable setup81% evidence BREAKING OUT 21.5/35 Revenue 11.8% · PAT 26.1% · OPM change 1.2 pp 83% evidence 15.2/25 ROCE 10.4% · OPM 12.7% 76% evidence 12.1/20 P/E 33× · PEG 1.33 65% evidence 17.0/20 RS sector 10.7% · RS bench -2.8% · 1Y 24.4%8 of 12 weeks ahead 100% evidence
Exact sum: 21.5 + 15.2 + 12.1 + 17 = 65.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3HEICO CorporationHEI 60.0/100Mixed-positive evidence81% evidence ASLEEP 24.3/35 Revenue 18.8% · PAT 30.2% · OPM change 2.9 pp 83% evidence 14.7/25 ROCE 4.3% · OPM 25.5% 76% evidence 10.4/20 P/E 48.2× · PEG 1.56 65% evidence 10.6/20 RS sector -0.7% · RS bench -12.7% · 1Y -6.1%8 of 12 weeks ahead 100% evidence
Exact sum: 24.3 + 14.7 + 10.4 + 10.6 = 60 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
4Elbit Systems Ltd.ESLT 59.8/100Mixed-positive evidence81% evidence ASLEEP 22.4/35 Revenue 13.7% · PAT 60.2% · OPM change 1.6 pp 83% evidence 11.7/25 ROCE 3.1% · OPM 9.6% 76% evidence 11.7/20 P/E 57.2× · PEG 1.13 65% evidence 14.0/20 RS sector 12.2% · RS bench -1.9% · 1Y 51.3%1 of 12 weeks ahead 100% evidence
Exact sum: 22.4 + 11.7 + 11.7 + 14 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Howmet Aerospace Inc.HWM 59.7/100Mixed-positive evidence81% evidence ASLEEP 24.6/35 Revenue 18.1% · PAT 33.9% · OPM change 2.5 pp 83% evidence 16.3/25 ROCE 7% · OPM 27.9% 76% evidence 9.0/20 P/E 57.9× · PEG 1.62 65% evidence 9.8/20 RS sector 2.6% · RS bench -9.8% · 1Y 19.7%3 of 12 weeks ahead 100% evidence
Exact sum: 24.6 + 16.3 + 9 + 9.8 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Embraer S.A.EMBJ 58.3/100Mixed-positive evidence66% evidence BREAKING OUT 16.5/35 Revenue 20% · PAT -22.2% · OPM change 1 pp 53% evidence 7.6/25 ROCE 1.1% · OPM 5.6% 57% evidence 14.2/20 P/E 54.9× · PEG 0.51 65% evidence 20.0/20 RS sector 21% · RS bench 6.4% · 1Y 27.7%8 of 12 weeks ahead 100% evidence
Exact sum: 16.5 + 7.6 + 14.2 + 20 = 58.3 · Decision use: Price leads the evidence: RS versus the benchmark is 6.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
7General Dynamics CorporationGD 56.7/100Thin evidence · provisional58% evidence FADING 17.0/35 Revenue — · PAT — · OPM change 0.1 pp 45% evidence 12.5/25 ROCE 3.7% · OPM 10.4% 76% evidence 11.0/20 P/E 22.8× · PEG — 15% evidence 16.2/20 RS sector 8.7% · RS bench -4.4% · 1Y 11.1%6 of 12 weeks ahead 100% evidence
Exact sum: 17 + 12.5 + 11 + 16.2 = 56.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8Hexcel CorporationHXL 56.0/100Thin evidence · provisional56% evidence FADING 20.8/35 Revenue — · PAT — · OPM change 1.8 pp 39% evidence 10.8/25 ROCE 2.9% · OPM 11.5% 76% evidence 10.0/20 P/E 50.3× · PEG — 15% evidence 14.4/20 RS sector 14.1% · RS bench 0.4% · 1Y 47.2%7 of 12 weeks ahead 100% evidence
Exact sum: 20.8 + 10.8 + 10 + 14.4 = 56 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9GE AerospaceGE 54.5/100Mixed-positive evidence81% evidence ASLEEP 19.4/35 Revenue 21.7% · PAT 16.2% · OPM change -0.3 pp 83% evidence 16.4/25 ROCE 11.7% · OPM 20.6% 76% evidence 7.3/20 P/E 43.5× · PEG 2.38 65% evidence 11.4/20 RS sector 4.8% · RS bench -7.8% · 1Y 3.9%8 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 16.4 + 7.3 + 11.4 = 54.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Curtiss-Wright CorporationCW 52.7/100Mixed-positive evidence81% evidence ASLEEP 21.8/35 Revenue 10.5% · PAT 20% · OPM change 1.5 pp 83% evidence 19.5/25 ROCE 17.4% · OPM 19.4% 76% evidence 7.4/20 P/E 51.7× · PEG 2.28 65% evidence 4.0/20 RS sector -6.4% · RS bench -17.9% · 1Y 10.7%0 of 12 weeks ahead 100% evidence
Exact sum: 21.8 + 19.5 + 7.4 + 4 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Woodward, Inc.WWD 52.6/100Thin evidence · provisional56% evidence ASLEEP 20.4/35 Revenue — · PAT — · OPM change 1.2 pp 39% evidence 14.3/25 ROCE 4.9% · OPM 14.7% 76% evidence 9.9/20 P/E 50.5× · PEG — 15% evidence 8.0/20 RS sector -0.2% · RS bench -12.5% · 1Y 33.7%1 of 12 weeks ahead 100% evidence
Exact sum: 20.4 + 14.3 + 9.9 + 8 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Loar Holdings Inc.LOAR 50.3/100Thin evidence · provisional56% evidence ASLEEP 18.7/35 Revenue 26.3% · PAT 91.7% · OPM change -1.3 pp 53% evidence 10.3/25 ROCE 1.8% · OPM 21.5% 57% evidence 9.1/20 P/E 80.7× · PEG — 15% evidence 12.2/20 RS sector -0.4% · RS bench -12.4% · 1Y -19.2%7 of 12 weeks ahead 100% evidence
Exact sum: 18.7 + 10.3 + 9.1 + 12.2 = 50.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Leonardo DRS, Inc.DRS 49.0/100Thin evidence · provisional56% evidence ASLEEP 20.3/35 Revenue — · PAT — · OPM change 1.7 pp 39% evidence 11.8/25 ROCE 3.3% · OPM 9.1% 76% evidence 10.7/20 P/E 35.9× · PEG — 15% evidence 6.2/20 RS sector -4% · RS bench -15.9% · 1Y -10.5%2 of 12 weeks ahead 100% evidence
Exact sum: 20.3 + 11.8 + 10.7 + 6.2 = 49 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14Textron Inc.TXT 46.2/100Thin evidence · provisional56% evidence BASING 15.9/35 Revenue — · PAT — · OPM change -0.8 pp 39% evidence 9.3/25 ROCE 2% · OPM 6.3% 76% evidence 11.3/20 P/E 17.4× · PEG — 15% evidence 9.7/20 RS sector -2.9% · RS bench -14.9% · 1Y -3.5%1 of 12 weeks ahead 100% evidence
Exact sum: 15.9 + 9.3 + 11.3 + 9.7 = 46.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
15Northrop Grumman CorporationNOC 44.9/100Mixed-negative evidence81% evidence TURNING 9.9/35 Revenue 5.9% · PAT 14% · OPM change -3.7 pp 83% evidence 10.7/25 ROCE 3% · OPM 10.1% 76% evidence 14.5/20 P/E 16.2× · PEG 1.01 65% evidence 9.8/20 RS sector -5.5% · RS bench -17.5% · 1Y -7.4%0 of 12 weeks ahead 100% evidence
Exact sum: 9.9 + 10.7 + 14.5 + 9.8 = 44.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
16Axon Enterprise, Inc.AXON 44.8/100Mixed-negative evidence71% evidence BREAKING OUT 20.0/35 Revenue 34.6% · PAT -39% · OPM change 5.4 pp 83% evidence 6.4/25 ROCE 0.9% · OPM 5.2% 76% evidence 8.6/20 P/E 232.6× · PEG — 15% evidence 9.8/20 RS sector -6.2% · RS bench -17.4% · 1Y -39.5%11 of 12 weeks ahead 100% evidence
Exact sum: 20 + 6.4 + 8.6 + 9.8 = 44.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17CAE Inc.CAE 44.4/100Mixed-negative evidence66% evidence ASLEEP 10.7/35 Revenue 4.4% · PAT -22.4% · OPM change -7.6 pp 53% evidence 10.7/25 ROCE 2% · OPM 12.9% 57% evidence 14.7/20 P/E 37.3× · PEG 0.68 65% evidence 8.3/20 RS sector -6.5% · RS bench -18.1% · 1Y -14%0 of 12 weeks ahead 100% evidence
Exact sum: 10.7 + 10.7 + 14.7 + 8.3 = 44.4 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
18The Boeing CompanyBA 43.8/100Mixed-negative evidence64% evidence ASLEEP 19.8/35 Revenue 24.8% · PAT — · OPM change 1.4 pp 62% evidence 4.1/25 ROCE 0.3% · OPM 0.6% 76% evidence 9.0/20 P/E 93.7× · PEG — 15% evidence 10.9/20 RS sector -1.2% · RS bench -13.4% · 1Y -6.3%0 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 4.1 + 9 + 10.9 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Huntington Ingalls Industries, Inc.HII 43.6/100Thin evidence · provisional56% evidence BASING 16.6/35 Revenue — · PAT — · OPM change -0.9 pp 39% evidence 9.4/25 ROCE 2.2% · OPM 5% 76% evidence 11.4/20 P/E 16.7× · PEG — 15% evidence 6.2/20 RS sector -11.8% · RS bench -23.2% · 1Y 1.1%0 of 12 weeks ahead 100% evidence
Exact sum: 16.6 + 9.4 + 11.4 + 6.2 = 43.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20StandardAero, Inc.SARO 42.9/100Thin evidence · provisional56% evidence ASLEEP 18.4/35 Revenue 15% · PAT 100% · OPM change -0.2 pp 53% evidence 9.2/25 ROCE 2.8% · OPM 8.8% 57% evidence 10.9/20 P/E 29.4× · PEG — 15% evidence 4.4/20 RS sector -10.4% · RS bench -21.6% · 1Y -16.1%4 of 12 weeks ahead 100% evidence
Exact sum: 18.4 + 9.2 + 10.9 + 4.4 = 42.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21TransDigm Group IncorporatedTDG 41.7/100Mixed-negative evidence81% evidence ASLEEP 15.3/35 Revenue 16.6% · PAT 10.3% · OPM change -1.6 pp 83% evidence 15.9/25 ROCE 5.5% · OPM 44.8% 76% evidence 5.3/20 P/E 40.2× · PEG 4.28 65% evidence 5.2/20 RS sector -9.4% · RS bench -20.5% · 1Y -15.8%0 of 12 weeks ahead 100% evidence
Exact sum: 15.3 + 15.9 + 5.3 + 5.2 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Rocket Lab CorporationRKLB 40.5/100Mixed-negative evidence61% evidence ASLEEP 25.1/35 Revenue 52.6% · PAT — · OPM change 16.7 pp 62% evidence 3.1/25 ROCE -2.4% · OPM -24.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 2.3/20 RS sector -9.3% · RS bench -20.5% · 1Y 33.3%2 of 12 weeks ahead 100% evidence
Exact sum: 25.1 + 3.1 + 10 + 2.3 = 40.5 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -9.3% and the one-year return is 33.3%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
23L3Harris Technologies, Inc.LHX 39.8/100Thin evidence · provisional58% evidence BASING 17.3/35 Revenue — · PAT — · OPM change 0.6 pp 45% evidence 10.2/25 ROCE 1.9% · OPM 11.1% 76% evidence 8.8/20 P/E 96× · PEG — 15% evidence 3.5/20 RS sector -13% · RS bench -24% · 1Y -11.7%0 of 12 weeks ahead 100% evidence
Exact sum: 17.3 + 10.2 + 8.8 + 3.5 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24FTAI Aviation Ltd.FTAI 38.4/100Thin evidence · provisional56% evidence ASLEEP 12.8/35 Revenue — · PAT — · OPM change -9.6 pp 39% evidence 13.4/25 ROCE 5% · OPM 20.5% 76% evidence 9.2/20 P/E 58.8× · PEG — 15% evidence 3.0/20 RS sector -8% · RS bench -19.9% · 1Y 6.1%0 of 12 weeks ahead 100% evidence
Exact sum: 12.8 + 13.4 + 9.2 + 3 = 38.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
25AeroVironment, Inc.AVAV 37.7/100Mixed-negative evidence71% evidence BASING 17.6/35 Revenue 100% · PAT -702.3% · OPM change 3.9 pp 83% evidence 6.1/25 ROCE 1.8% · OPM 8.9% 76% evidence 8.7/20 P/E 97.8× · PEG — 15% evidence 5.3/20 RS sector -28.4% · RS bench -37.4% · 1Y -43.8%2 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 6.1 + 8.7 + 5.3 = 37.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Kratos Defense & Security Solutions, Inc.KTOS 37.1/100Thin evidence · provisional56% evidence ASLEEP 18.2/35 Revenue 21.9% · PAT 50% · OPM change -0.9 pp 53% evidence 6.4/25 ROCE 0.2% · OPM 1.3% 57% evidence 8.5/20 P/E 423.2× · PEG — 15% evidence 4.0/20 RS sector -30.2% · RS bench -39.4% · 1Y -41.1%1 of 12 weeks ahead 100% evidence
Exact sum: 18.2 + 6.4 + 8.5 + 4 = 37.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
27BWX Technologies, Inc.this pageBWXT 34.2/100Adverse evidence66% evidence ASLEEP 16.4/35 Revenue 21.4% · PAT 19% · OPM change -1.8 pp 53% evidence 11.2/25 ROCE 2.7% · OPM 9.9% 57% evidence 5.3/20 P/E 54.7× · PEG 2.86 65% evidence 1.3/20 RS sector -18.7% · RS bench -28.8% · 1Y -16.5%0 of 12 weeks ahead 100% evidence
Exact sum: 16.4 + 11.2 + 5.3 + 1.3 = 34.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28Moog Inc.MOG-B 53.2/100Thin evidence · provisional33% evidence FADING 19.5/35 Revenue — · PAT — · OPM change 1 pp 32% evidence 13.1/25 ROCE 4.4% · OPM 10.8% 76% evidence 10.6/20 P/E 36.1× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y 86.1%9 of 11 weeks ahead 0% evidence
Exact sum: 19.5 + 13.1 + 10.6 + 10 = 53.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Honeywell Aerospace Inc.HONA 42.7/100Thin evidence · provisional48% evidence ASLEEP 7.2/35 Revenue 10.1% · PAT -32.7% · OPM change -10.5 pp 83% evidence 15.5/25 ROCE 8.9% · OPM 12.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 1 week ahead 0% evidence
Exact sum: 7.2 + 15.5 + 10 + 10 = 42.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Space Exploration Technologies Corp.SPCX 39.8/100Thin evidence · provisional33% evidence ASLEEP 16.4/35 Revenue — · PAT — · OPM change 17.2 pp 39% evidence 3.4/25 ROCE -1.6% · OPM -1.8% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 10.0/20 RS sector — · RS bench — · 1Y —0 of 1 week ahead 0% evidence
Exact sum: 16.4 + 3.4 + 10 + 10 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is BWX Technologies, Inc.'s stock price today?

BWX Technologies, Inc. trades at $146, −16.5% over the past year. The company is valued at $13.0 B. The stock sits at the very bottom of its 52-week range ($146–$236), −24.1% versus its 200-day average. On the tape, the price is building a base, 12 weeks in. — as of 17 September 2026.

What were BWX Technologies, Inc.'s latest quarterly results?

BWX Technologies, Inc. reported revenue of $0.9 B and net profit of $0.1 B for the Mar 26 quarter. Revenue rose 26.5% and profit rose 12.5% year on year. Earnings per share were $0.99. The operating margin was 10.5%, 1.3 pp lower than a year earlier. — as of 17 September 2026.

What is BWX Technologies, Inc.'s revenue?

BWX Technologies, Inc. reported revenue of $0.9 B in the Mar 26 quarter, +26.5% year on year. For the full FY25 fiscal year, revenue was $3.2 B (+18.5%). Over the last 4 years revenue compounded at 10.8% a year. — as of 17 September 2026.

What is BWX Technologies, Inc.'s profit?

BWX Technologies, Inc. earned $0.1 B of net profit in the Mar 26 quarter, +12.5% year on year — the 5th straight quarter of growth. Full-year FY25 profit was $0.3 B. The operating margin ran 10.5% in the latest quarter. — as of 17 September 2026.

What is BWX Technologies, Inc.'s market cap?

BWX Technologies, Inc.'s market capitalisation is $13.0 B at a stock price of $146. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 17 September 2026.

What is BWX Technologies, Inc.'s P/E ratio?

BWX Technologies, Inc. trades at a P/E of 37.7×, at the 63rd percentile of its own 5-year range, against a long-run median of 33.3×. This is a comparison with the stock's own history, not a value call — as of 17 September 2026.

Does BWX Technologies, Inc. pay a dividend?

Yes — BWX Technologies, Inc. declared $0.27 per share for Mar 26, and $1.02 per share across the last four reported quarters. The latest quarter is up 8.0% on the same quarter a year earlier. — as of 17 September 2026.

What is BWX Technologies, Inc.'s dividend per share?

BWX Technologies, Inc.'s most recently declared dividend is $0.27 per share for Mar 26, giving $1.02 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 17 September 2026.

What is BWX Technologies, Inc.'s dividend yield?

BWX Technologies, Inc.'s trailing dividend yield is 0.70%: $1.02 declared per share across the last four reported quarters, against a share price of $146. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 17 September 2026.

Is BWX Technologies, Inc. overvalued?

On its own history, BWX Technologies, Inc. looks mid-range: its P/E of 37.7× sits at the 63rd percentile of its 5-year range (long-run median 33.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 17 September 2026.

Is BWX Technologies, Inc. growing?

Yes — BWX Technologies, Inc. is growing: latest-quarter revenue +26.5% year on year, profit +12.5%, and the margin −1.3 pp at 10.5%. The 4-year compound rates are 10.8% (revenue) and 1.6% (profit). The earnings engine currently reads: improving — as of 17 September 2026.

How is BWX Technologies, Inc. performing?

BWX Technologies, Inc. is building a base, 12 weeks in. Its latest quarter's revenue rose 26.5% and profit rose 12.5% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 20 weeks. This describes what the data did, not a rating. — as of 17 September 2026.

What stage is BWX Technologies, Inc. in?

Mixed — the growth curves are steadily positive, but ROCE at 10.6% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +21.6% latest, profit growth +17.2% latest, eps growth +19.1% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 17 September 2026.

Is BWX Technologies, Inc. in an uptrend?

No — the price is building a base (week 12 of stage 1), trading −24.1% versus its 200-day average and at the very bottom of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 17 September 2026.

Is BWX Technologies, Inc. beating the market?

Not lately — on a trailing-13-week view BWX Technologies, Inc. is currently behind the S&P 500 (20 weeks and counting; last ahead the week of 2026-05-01), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved +308% against the S&P 500's +255% — ahead of the index over the full window. — as of 17 September 2026.

Will BWX Technologies, Inc.'s stock price go up?

This page publishes no price forecast for BWX Technologies, Inc. What it measures instead: the stock price is $146, the price is building a base 12 weeks in. Its P/E of 37.7× sits at the 63rd percentile of its own 5-year range. — as of 17 September 2026.

Is the market betting against BWX Technologies, Inc.?

Somewhat — short interest is 3.3% of BWX Technologies, Inc.'s tradable float, about 2.9 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 17 September 2026.

Does BWX Technologies, Inc. have too much debt?

It carries real leverage — BWX Technologies, Inc.'s debt-to-equity is 1.51. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 17 September 2026.

What is BWX Technologies, Inc.'s capex?

BWX Technologies, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.2 B. — as of 17 September 2026.

What is BWX Technologies, Inc.'s cash flow?

BWX Technologies, Inc. generated $0.5 B of operating cash flow in FY25 and $0.3 B of free cash flow after $0.2 B of capital spending. Reported profit that year was $0.3 B, so operating cash ran ahead of profit. — as of 17 September 2026.

Is BWX Technologies, Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 145% of BWX Technologies, Inc.'s reported profit arrived as operating cash. In FY25, operating cash was $0.5 B against reported profit of $0.3 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 17 September 2026.

How financially safe is BWX Technologies, Inc.?

On the balance sheet, the Z-score reads 5.54 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 17 September 2026.

Where is BWX Technologies, Inc. in its business cycle?

BWX Technologies, Inc.'s FY25 operating margin was 10.3%, against a 5-year band of 10.3%–14.6%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 10.5%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 17 September 2026.

What could break the BWX Technologies, Inc. story?

The sharpest disagreement: annual EPS moved +16.6% against a −16.5% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 17 September 2026.

Is BWX Technologies, Inc. a stock worth studying right now?

This is not investment advice. The machine read: BWX Technologies, Inc.'s earnings have outrun its stock. EPS grew +16.6% in a year against a −16.5% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 17 September 2026.

Sector Alpha — machine-written from the numbers · Data as of 2026-09-17. Every chart on this page is drawn by deterministic code from the raw series — no forecasts, no price opinions, and nothing here is investment advice.

Not SEBI Registered !! Not Investment advice !!

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI